Vital Signs - Continued Opportunities in Diabetes Drug Delivery
Vital Signs - Continued Opportunities in Diabetes Drug Delivery
RELEASE DATE
26-Jan-2009
26-Jan-2009
REGION
North America
North America
Research Code: 9561-00-81-00-00
SKU: HC00560-NA-MR_04032
$1,500.00
In stock
SKU
HC00560-NA-MR_04032
Description
This issue of Vital Signs, released on January 26, 2009, provides a strategic overview of opportunities in drug delivery for the treatment of diabetes. Additionally, a company spotlight is provided for NanoBio Corporation, a company focused on the development and commercialization of topical and vaccine products utilizing its NanoStat technology platform. Reimbursement and regulatory news from the FDA is also provided for the week of January 12, 2009.
Table of Contents
This week's issue:
Related Research
Popular Topics
This issue of Vital Signs, released on January 26, 2009, provides a strategic overview of opportunities in drug delivery for the treatment of diabetes. Additionally, a company spotlight is provided for NanoBio Corporation, a company focused on the development and commercialization of topical and vaccine products utilizing its NanoStat technology platform. Reimbursement and regulatory news from the FDA is also provided for the week of January 12, 2009.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-81-00-00 |
Is Prebook | No |